Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Lamellasome IPF-NA
- Development stage
- Preclinical
- Lead developer
- Lamellar Biomedical
- Modality
- RNA Therapeutics → Nucleic Acid Therapeutics, Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Administration
- Inhalation
01
Overview
Lamellasome IPF-NA is a microRNA-based therapeutic candidate developed by Lamellar Biomedical for the treatment of idiopathic pulmonary fibrosis (IPF). It utilizes the proprietary LAMELLASOME platform, which consists of synthetic lipidic vesicles designed to deliver nucleic acid therapeutics—including microRNAs, siRNAs, and mRNAs—directly to lung tissue via inhalation or nebulization. The therapy aims to reduce inflammatory responses, interrupt the progression of pulmonary fibrosis, and modulate tissue surface tension in the lungs. As a nucleic acid-based biologic, it represents a novel approach to treating progressive and fatal interstitial lung diseases by delivering regulatory molecules to affected tissues.
- Brand names
- LAMELLASOME IPF-NA
Beyond the preview
Go deeper on Lamellasome IPF-NA.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Lamellasome IPF-NA.